P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKADE IN ANTI–PD-1–NAIVE PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: AN OPEN-LABEL PHASE 1/2 STUDY... by G. Gregory, J. Timmerman, D. Lavie, P. Borchmann, A. F. Herrera, L. Minuk, V. Vucinic, P. Armand, A. Avigdor, R. Gasiorowski, Y. Herishanu, C. Keane, J. Kuruvilla, J. Palcza, P. Pillai, P. Marinello, N. A. Johnson

Get full text